Skip to main content
. 2010 Jun 14;28(22):3555–3561. doi: 10.1200/JCO.2009.27.5719

Fig A2.

Fig A2.

Association of BRCAness profile with disease-free survival (DFS) and overall survival (OS) in the sequenced patient cohort (n = 35). (A) DFS in the sequenced patient cohort. The median DFS times for patients with the BRCA-like (BL) and non–BRCA-like (NBL) profiles were not yet reached at median follow-up times of 53.5 months and 20 months, respectively (log-rank P = .03). (B) OS in the sequenced patient cohort. The median OS times for patients with the BL and NBL profiles were 72 months and 48 months, respectively (log-rank P = .1).